These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2449865)

  • 1. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.
    Retsema J; Girard A; Schelkly W; Manousos M; Anderson M; Bright G; Borovoy R; Brennan L; Mason R
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1939-47. PubMed ID: 2449865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of the new oral macrolide azithromycin.
    Neu HC; Chin NX; Saha G; Labthavikul P
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):541-4. PubMed ID: 2846300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin.
    Retsema JA; Girard AE; Brennan LA; Cimochowski CR; Faiella JA
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):843-6. PubMed ID: 1662628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of activity of azithromycin.
    Williams JD
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):813-20. PubMed ID: 1662624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of environmental factors on the in vitro potency of azithromycin.
    Retsema JA; Brennan LA; Girard AE
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):834-42. PubMed ID: 1662627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
    Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
    Dunkin KT; Jones S; Howard AJ
    J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of RU-66647, a new ketolide.
    Jones RN; Biedenbach DJ
    Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T; Neu HC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
    Jones K; Felmingham D; Ridgway G
    Drugs Exp Clin Res; 1988; 14(10):613-5. PubMed ID: 2854515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
    Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
    Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
    Pavlović D; Fajdetić A; Mutak S
    Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azithromycin: critical points].
    Philippon A; Cluzel R; Soussy CJ
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1988 May; 32(5):752-4. PubMed ID: 2840016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ureas and thioureas of 15-membered azalides with antibacterial activity against key respiratory pathogens.
    Bukvić Krajacić M; Novak P; Dumić M; Cindrić M; Paljetak HC; Kujundzić N
    Eur J Med Chem; 2009 Sep; 44(9):3459-70. PubMed ID: 19303171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of MC-352, a new 16-membered macrolide.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.